About this trial
Periodontitis is a chronic, multifactorial inflammatory disease primarily caused by dysbiotic plaque biofilms, characterized by the progressive destruction of the supporting structures of the teeth. In advanced stages (Stage III/IV), periodontitis leads to significant attachment and bone loss, often culminating in tooth loss and a negative impact on the patient's quality of life. Recent evidence has emphasized the systemic implications of periodontal inflammation, suggesting a bidirectional relationship between periodontitis and various systemic conditions, especially cardiovascular diseases
Eligibility criteria
Qualifiers
Age 30-60 years.
Systemically healthy (based on medical history and physician clearance, if needed).
No history of periodontal treatment within the last 6 months.
Disqualifiers
1. History of systemic diseases affecting periodontium (e.g., uncontrolled diabetes, autoimmune diseases, osteoporosis).
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
shaimaa hamdy
Lead sponsor
Minia University
Sponsor institution